Skip to main content
Premium Trial:

Request an Annual Quote

Protein Discovery Awarded Phase I SBIR Grant for Serum Fractionation

NEW YORK, March 8 (GenomeWeb News) - The National Institutes of Health has awarded Protein Discovery a Phase I SBIR Grant to help the company develop a fractionation system that prepares human serum for high-throuput mass-spectrometry analysis.


Protein Discovery's system "is compatible with all major MALDI mass spectrometers and can be automated, so we are excited about the tremendous value this system will provide to organizations involved in proteomics research and biomarker discovery," said president and CEO Chuck Witkowski in a statement.


The amount of the grant was not disclosed, though Phase I SBIR grants are typically $100,000.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.